EGFR and non-small cell lung carcinoma: For example, Asian patients more frequently present with EGFR-mt NSCLC (34–67%) than patients in other regions (8–26%).21 It is also known that the use of EGFR-TKI causes interstitial pneumonia more often in Asian populations.22